Background
People with HIV (PWH) with low CD4 count are at high risk for severe and prolonged mpox. Data on immune response and its persistence after MVA-BN vaccination are lacking. We evaluated humoral and cellular responses 3 years after MVA-BN vaccination in PWH and people without HIV (PWoH), according to CD4 count.
Methods
Blood samples were collected 3 years after the primary course of MVA vaccination (single dose in smallpox vaccine-experienced individuals; two doses in naïve individuals) across three centres of the Italian multicentre ICONA cohort. Anti-MPXV IgG and neutralizing antibodies (nAb) were measured by immunofluorescence assay and PRNT50. Orthopox (OP)-specific T-cell responses were assessed by ELISpot and intracellular cytokine staining (ICS) with multiparametric flow cytometry. Statistical analyses included Kruskal-Wallis, Dunn’s, Mann-Whitney, and Wilcoxon tests.
Results
We analysed 92 male participants: 51 PWoH, 27 PWH with CD4 >350 cells/µL, and 14 PWH with CD4 counts <350 cells/µL. Smallpox vaccine-naïve individuals showed lower IgG titers compared to those who were smallpox vaccine-experienced, across all three groups (p = 0.0020, p = 0.0028, p = 0.0495). A similar pattern was observed for nAbs (Fig. 1A). No evidence for a difference emerged in the comparison of HIV strata. T-cell analyses confirmed persistent responses: OP-derived CD4 responses were significantly higher in PWoH and PWH with CD4 >350 than in PWH with CD4 <350, while CD8 responses showed a similar but non-significant trend. MVA-BN–specific T-cell responses, both CD4 and CD8, were detectable in all groups, including PWH with CD4 <350 (Fig. 1B). ICS preliminary data showed multifunctional Th1 responses in both PWoH and PWH, with higher levels in vaccine-experienced individuals, particularly within CD4 TEMRA and CD8 TEMRA subsets.
Conclusions
Three years after MVA-BN vaccination, humoral response, both IgG and nAb, persisted in smallpox-primed individuals, including PWH with advanced immunosuppression. Smallpox-naïve individuals elicited a poor humoral residual response, which supports the need for a booster dose to increase protection. A significant T-specific CD4 and CD8 response to orthopox antigens was still observed in PWoH and PWH with CD4>350, compared to PWH with CD4<350. The presence of durable CD4 and CD8 memory responses in vaccine-experienced individuals with immune competence supports long-term immunological memory and suggests potential protection against mpox reinfection.
Table or Figure
